Shift Work Sleep Disorder (SWSD) affects up to 40% of U.S. shift workers, Luckily, it’s treatable. Before most of America ...

A man in his 50s with poorly controlled diabetes and chronic kidney disease presented with rapidly progressive bilateral ...

Lilly’s takeover of Engage Bio marks the seventh acquisition for the big pharma since the start of 2026.

At ASCO and EHA 2026, BeOne will showcase its hematology leadership with data spanning foundational therapies and next-generation innovation across CLL, mantle cell lymphoma and other B-cell ...

State-Funded Firefighter Cancer Screening Programs Expected to Drive Meaningful Revenue Growth Beginning in Q2 2026 $5.0 ...

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

EMERALD-3: Phase III trial of IMFINZI ® (durvalumab) in combination with IMJUDO ® (tremelimumab-actl), with or without lenvatinib, and transarterial chemoembolization (TACE) in patients with ...

Sleep breathing disorders (SBDs)—including obstructive sleep apnoea, central sleep apnoea and sleep-related hypoventilation syndromes—represent a major yet under-recognised contributor to global ...

New research from the Francis Crick Institute and Adendra Therapeutics shows that immune cells can be redirected to recognise cancer by exploiting F‑actin, a structural protein exposed when tumour ...

A multi-stage attack on Linux devices began with an exposed F5 BIG-IP edge appliance and pivoted to an internal Confluence ...